Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#61 / 189 Total
CAPR - Capricor Therapeutics Inc - Stock Price Chart
TickerCAPR [NASD]
CompanyCapricor Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap197.22MEPS (ttm)-0.88
P/E-EPS this Y-41.93%
Forward P/E-EPS next Y25.30%
PEG-EPS past 5Y30.59%
P/S7.28EPS next 5Y-
P/B10.63EPS Q/Q-1.53%
Dividend-Sales Q/Q64.29%
Insider Own8.34%Inst Own15.15%
Insider Trans0.00%Inst Trans7.69%
Short Float14.20%EarningsMay 13/a
Analyst Recom1.00Target Price19.80
Avg Volume350.10K52W Range2.68 - 8.22
May-17-24Initiated Oppenheimer Outperform $14
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COLLIER EARL M JRDirectorApr 23 '24Option Exercise1.3930,00041,70056,856Apr 25 09:15 AM
Musket David BDirectorApr 23 '24Option Exercise1.3916,15622,45747,692Apr 24 01:30 PM
Bergmann AnthonyCHIEF FINANCIAL OFFICEROct 23 '23Option Exercise1.392,1783,0272,381Oct 24 09:25 AM
Musket David BDirectorOct 12 '23Buy2.754101,12831,536Oct 13 01:59 PM
COLLIER EARL M JRDirectorOct 10 '23Buy2.8310,00028,30026,856Oct 12 09:15 AM
FTHM - Fathom Holdings Inc - Stock Price Chart
TickerFTHM [NASD]
CompanyFathom Holdings Inc
CountryUSA
IndustryReal Estate Services
Market Cap37.11MEPS (ttm)-1.42
P/E-EPS this Y60.52%
Forward P/E-EPS next Y85.00%
PEG-EPS past 5Y-64.63%
P/S0.11EPS next 5Y-
P/B0.71EPS Q/Q13.23%
Dividend-Sales Q/Q-9.08%
Insider Own39.57%Inst Own21.43%
Insider Trans-6.69%Inst Trans-11.61%
Short Float1.71%EarningsMay 09/a
Analyst Recom1.00Target Price4.50
Avg Volume64.39K52W Range1.32 - 8.20
Fathom Holdings, Inc. is a national, technology driven, end to end real estate services company, which engages in the provision of residential, brokerage, mortgage, title, insurance, and SaaS offerings for brokers and agents. It operates through the following segments: Real Estate Brokerage, Mortgage, Technology, and Corporate and Other Services. The company was founded by Joshua Harley in January 2010 and is headquartered in Cary, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flanders Scott NDirectorMay 15 '24Buy1.4925,00037,278521,100May 15 06:03 PM
Flanders Scott NDirectorMay 14 '24Buy1.4925,00037,370496,100May 15 06:03 PM
Flanders Scott NDirectorMay 13 '24Buy1.5025,00037,568471,100May 15 06:03 PM
Hood David C.DirectorMay 13 '24Buy1.5115,00022,64634,875May 14 04:48 PM
Murray Stephen H.DirectorDec 14 '23Buy2.6618,81750,05334,249Dec 18 04:10 PM
GSUN - Golden Sun Health Technology Group Ltd - Stock Price Chart
TickerGSUN [NASD]
CompanyGolden Sun Health Technology Group Ltd
CountryChina
IndustryEducation & Training Services
Market Cap27.87MEPS (ttm)-0.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S4.52EPS next 5Y-
P/B21.68EPS Q/Q17.76%
Dividend-Sales Q/Q-27.16%
Insider Own78.47%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float2.12%Earnings-
Analyst Recom-Target Price-
Avg Volume761.13K52W Range2.21 - 12.50
Golden Sun Health Technology Group Ltd. is a holding company, which engages in the provision of tutorial services. It focuses on the development of each of students' strengths and potential, and the promotion of life-long skills and interests in learning. The company was founded in 1997 and is headquartered in Shanghai, China.
IMMX - Immix Biopharma Inc - Stock Price Chart
TickerIMMX [NASD]
CompanyImmix Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap65.23MEPS (ttm)-0.95
P/E-EPS this Y-24.00%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-63.30%
P/S-EPS next 5Y-
P/B2.34EPS Q/Q-25.78%
Dividend-Sales Q/Q-
Insider Own45.99%Inst Own19.39%
Insider Trans0.54%Inst Trans19.80%
Short Float2.72%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume174.14K52W Range1.40 - 7.75
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morris Gabriel SCFOMay 14 '24Buy2.234,50010,04285,816May 14 09:29 PM
Rachman Ilya MCEO and ChairmanMay 14 '24Buy2.254,3009,660912,000May 14 09:28 PM
Hsu JasonDirectorDec 11 '23Buy4.6731,000144,894813,000Dec 12 06:25 PM
Hsu JasonDirectorDec 08 '23Buy4.8825,000122,025782,000Dec 12 06:25 PM
Hsu JasonDirectorSep 15 '23Buy2.497,00017,396757,000Sep 18 07:03 PM
FBIO - Fortress Biotech Inc - Stock Price Chart
TickerFBIO [NASD]
CompanyFortress Biotech Inc
CountryUSA
IndustryBiotechnology
Market Cap37.11MEPS (ttm)-19.52
P/E-EPS this Y44.39%
Forward P/E-EPS next Y31.92%
PEG-EPS past 5Y22.28%
P/S0.44EPS next 5Y25.50%
P/B1.62EPS Q/Q67.40%
Dividend-Sales Q/Q4.84%
Insider Own27.05%Inst Own15.96%
Insider Trans0.97%Inst Trans-12.79%
Short Float12.50%EarningsMay 15/a
Analyst Recom1.00Target Price13.00
Avg Volume245.74K52W Range1.24 - 10.65
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanJan 05 '24Buy2.3850,000118,7702,863,905Jan 09 08:15 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanNov 14 '23Buy1.701,567,5152,664,7762,597,440Nov 16 05:50 PM
WEISS MICHAEL SSee RemarksNov 14 '23Buy1.70147,058249,9991,130,520Nov 16 05:46 PM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanSep 26 '23Buy0.28100,00028,33015,449,091Sep 27 08:20 AM
Fortress Biotech, Inc.10% OwnerSep 08 '23Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
TNYA - Tenaya Therapeutics Inc - Stock Price Chart
TickerTNYA [NASD, RUT]
CompanyTenaya Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap365.90MEPS (ttm)-1.68
P/E-EPS this Y5.51%
Forward P/E-EPS next Y-1.94%
PEG-EPS past 5Y-27.43%
P/S-EPS next 5Y-
P/B2.31EPS Q/Q8.34%
Dividend-Sales Q/Q-
Insider Own20.30%Inst Own55.84%
Insider Trans38.27%Inst Trans-5.76%
Short Float5.81%EarningsMay 14/a
Analyst Recom1.00Target Price19.29
Avg Volume447.20K52W Range1.66 - 8.09
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hoey TimothyChief Scientific OfficerMar 05 '24Sale7.003,30023,101245,346Mar 06 06:45 PM
Hoey TimothyChief Scientific OfficerFeb 20 '24Sale5.346,56935,046236,146Feb 21 06:05 PM
Tingley WhittemoreChief Medical OfficerFeb 16 '24Sale5.866,50038,09073,534Feb 16 08:35 PM
Ali FarazChief Executive OfficerFeb 16 '24Sale5.866,35837,258113,079Feb 16 08:30 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerFeb 16 '24Sale5.865,20130,47860,755Feb 16 08:32 PM
BIMI - BIMI Holdings Inc. - Stock Price Chart
TickerBIMI [NASD]
CompanyBIMI Holdings Inc.
CountryUSA
IndustryPharmaceutical Retailers
Market Cap14.60MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.28%
P/S-EPS next 5Y-
P/B0.97EPS Q/Q73.16%
Dividend-Sales Q/Q-48.79%
Insider Own91.93%Inst Own0.15%
Insider Trans-0.04%Inst Trans5.99%
Short Float2.94%EarningsNov 27/b
Analyst Recom-Target Price-
Avg Volume49.59K52W Range0.80 - 4.13
BIMI International Medical, Inc. engages in the provision of healthcare products and services. It operates through the following segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. The Wholesale Pharmaceuticals segment includes supplying prescription and OTC medicines, TCM, healthcare supplies and sundry items to clinics, third party pharmacies, hospitals, and other drug vendors. The Wholesale Medical Devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. The Medical Services segment includes the hospitals acquired in 2021.The Retail Pharmacy segment sells prescription and OTC medicines, traditional Chinese medicines ("TCM"), healthcare supplies, and sundry items to retail customers through its directly-owned pharmacies and authorized retail stores. The company was founded on October 31, 2000 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tiewei SongCEOFeb 28 '24Sale4.084,00016,300337,117Mar 04 04:01 PM
Tiewei SongCEOFeb 26 '24Sale4.017242,903341,117Mar 04 04:03 PM
IBIO - iBio Inc - Stock Price Chart
TickerIBIO [AMEX]
CompanyiBio Inc
CountryUSA
IndustryBiotechnology
Market Cap17.07MEPS (ttm)-16.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y32.72%
P/S341.35EPS next 5Y-
P/B0.68EPS Q/Q92.28%
Dividend-Sales Q/Q-
Insider Own0.16%Inst Own35.29%
Insider Trans0.00%Inst Trans1.54%
Short Float1.57%EarningsMay 13/a
Analyst Recom3.00Target Price20.00
Avg Volume3.92M52W Range1.02 - 19.35
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brenner MartinSee RemarksNov 01 '23Sale0.274,8811,296182,502Nov 03 04:01 PM
Brenner MartinSee RemarksOct 03 '23Sale0.305,2671,592187,383Oct 05 04:01 PM
Brenner MartinSee RemarksOct 02 '23Sale0.314,2151,311192,650Oct 03 04:01 PM
Brenner MartinSee RemarksAug 28 '23Sale0.315,0111,529196,865Aug 30 04:22 PM
Brenner MartinSee RemarksJul 27 '23Sale0.514,5152,308201,876Jul 28 04:01 PM
ENVX - Enovix Corporation - Stock Price Chart
TickerENVX [NASD, RUT]
CompanyEnovix Corporation
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap1.71BEPS (ttm)-1.35
P/E-EPS this Y-9.72%
Forward P/E-EPS next Y25.05%
PEG-EPS past 5Y-
P/S132.41EPS next 5Y-
P/B7.43EPS Q/Q41.68%
Dividend-Sales Q/Q25004.76%
Insider Own18.78%Inst Own49.20%
Insider Trans-0.02%Inst Trans-15.44%
Short Float31.09%EarningsMay 01/a
Analyst Recom1.15Target Price27.58
Avg Volume5.44M52W Range5.70 - 23.90
Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Marathe AjayChief Operating OfficerApr 14 '24Sale7.314,95436,214978,913Apr 16 12:49 PM
Talluri Rajendra KPresident and CEOAug 24 '23Buy13.941,43419,9902,018,901Aug 25 11:58 AM
ATKINS BETSY SDirectorAug 11 '23Sale16.2536,000585,000159,369Aug 11 06:54 PM
ATKINS BETSY SDirectorJun 20 '23Sale15.024,52868,011195,369Jun 21 08:05 PM
BKKT - Bakkt Holdings Inc - Stock Price Chart
TickerBKKT [NYSE, RUT]
CompanyBakkt Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap66.70MEPS (ttm)-14.07
P/E-EPS this Y71.84%
Forward P/E-EPS next Y34.22%
PEG-EPS past 5Y-
P/S0.04EPS next 5Y-
P/B1.18EPS Q/Q56.48%
Dividend-Sales Q/Q6480.79%
Insider Own6.49%Inst Own25.59%
Insider Trans4.73%Inst Trans-
Short Float17.31%EarningsMay 15/a
Analyst Recom2.00Target Price26.58
Avg Volume336.39K52W Range5.57 - 68.75
Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Intercontinental Exchange, Inc10% OwnerApr 25 '24Buy0.87350,880304,213649,934Apr 29 09:11 PM
Intercontinental Exchange, Inc10% OwnerMar 04 '24Buy0.872,762,0092,394,6627,476,345Mar 04 05:34 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 23 '24Sale0.8850,24744,047566,630Feb 26 09:28 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 08 '24Sale0.9819,32918,927638,157Feb 09 09:13 PM
D'Annunzio MarcGeneral Counsel & SecretaryJan 25 '24Sale1.2742,80754,249667,320Jan 29 07:19 PM
12345678910111219